Global Precision Cancer Diagnostic Tests Market Research Report 2026(Status and Outlook)
Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Precision Cancer Diagnostic Tests market size was estimated at USD 5361.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Precision Cancer Diagnostic Tests market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Precision Cancer Diagnostic Tests market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Precision Cancer Diagnostic Tests market.
Global Precision Cancer Diagnostic Tests Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
Market Segmentation (by Type)
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Precision Cancer Diagnostic Tests Market
Overview of the regional outlook of the Precision Cancer Diagnostic Tests Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Precision Cancer Diagnostic Tests, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Precision Cancer Diagnostic Tests market size was estimated at USD 5361.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Precision Cancer Diagnostic Tests market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Precision Cancer Diagnostic Tests market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Precision Cancer Diagnostic Tests market.
Global Precision Cancer Diagnostic Tests Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
Market Segmentation (by Type)
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Precision Cancer Diagnostic Tests Market
Overview of the regional outlook of the Precision Cancer Diagnostic Tests Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Precision Cancer Diagnostic Tests, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Precision Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Precision Cancer Diagnostic Tests Segment by Type
1.2.2 Precision Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRECISION CANCER DIAGNOSTIC TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Precision Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Precision Cancer Diagnostic Tests Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRECISION CANCER DIAGNOSTIC TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Precision Cancer Diagnostic Tests Product Life Cycle
3.3 Global Precision Cancer Diagnostic Tests Sales by Manufacturers (2020-2025)
3.4 Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2020-2025)
3.5 Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Precision Cancer Diagnostic Tests Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Precision Cancer Diagnostic Tests Market Competitive Situation and Trends
3.8.1 Precision Cancer Diagnostic Tests Market Concentration Rate
3.8.2 Global 5 and 10 Largest Precision Cancer Diagnostic Tests Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRECISION CANCER DIAGNOSTIC TESTS INDUSTRY CHAIN ANALYSIS
4.1 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRECISION CANCER DIAGNOSTIC TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Precision Cancer Diagnostic Tests Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Precision Cancer Diagnostic Tests Market
5.7 ESG Ratings of Leading Companies
6 PRECISION CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
6.3 Global Precision Cancer Diagnostic Tests Market Size by Type (2020-2025)
6.4 Global Precision Cancer Diagnostic Tests Price by Type (2020-2025)
7 PRECISION CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Precision Cancer Diagnostic Tests Market Sales by Application (2020-2025)
7.3 Global Precision Cancer Diagnostic Tests Market Size (M USD) by Application (2020-2025)
7.4 Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
8 PRECISION CANCER DIAGNOSTIC TESTS MARKET SALES BY REGION
8.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Region
8.2 Global Precision Cancer Diagnostic Tests Market Size by Region
8.2.1 Global Precision Cancer Diagnostic Tests Market Size by Region
8.2.2 Global Precision Cancer Diagnostic Tests Market Size by Region
8.3 North America
8.3.1 North America Precision Cancer Diagnostic Tests Sales by Country
8.3.2 North America Precision Cancer Diagnostic Tests Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Precision Cancer Diagnostic Tests Sales by Country
8.4.2 Europe Precision Cancer Diagnostic Tests Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Precision Cancer Diagnostic Tests Sales by Region
8.5.2 Asia Pacific Precision Cancer Diagnostic Tests Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Precision Cancer Diagnostic Tests Sales by Country
8.6.2 South America Precision Cancer Diagnostic Tests Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region
8.7.2 Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PRECISION CANCER DIAGNOSTIC TESTS MARKET PRODUCTION BY REGION
9.1 Global Production of Precision Cancer Diagnostic Tests by Region(2020-2025)
9.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
9.3 Global Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Precision Cancer Diagnostic Tests Production
9.4.1 North America Precision Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.4.2 North America Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Precision Cancer Diagnostic Tests Production
9.5.1 Europe Precision Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.5.2 Europe Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Precision Cancer Diagnostic Tests Production (2020-2025)
9.6.1 Japan Precision Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.6.2 Japan Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Precision Cancer Diagnostic Tests Production (2020-2025)
9.7.1 China Precision Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.7.2 China Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
10.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Agilent Technologies
10.2.1 Agilent Technologies Basic Information
10.2.2 Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
10.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Product Market Performance
10.2.4 Agilent Technologies Business Overview
10.2.5 Agilent Technologies SWOT Analysis
10.2.6 Agilent Technologies Recent Developments
10.3 Becton Dickinson and Company
10.3.1 Becton Dickinson and Company Basic Information
10.3.2 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
10.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Market Performance
10.3.4 Becton Dickinson and Company Business Overview
10.3.5 Becton Dickinson and Company SWOT Analysis
10.3.6 Becton Dickinson and Company Recent Developments
10.4 Bio-Rad Laboratories
10.4.1 Bio-Rad Laboratories Basic Information
10.4.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
10.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Market Performance
10.4.4 Bio-Rad Laboratories Business Overview
10.4.5 Bio-Rad Laboratories Recent Developments
10.5 Biocartis N.V.
10.5.1 Biocartis N.V. Basic Information
10.5.2 Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
10.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Product Market Performance
10.5.4 Biocartis N.V. Business Overview
10.5.5 Biocartis N.V. Recent Developments
10.6 Biocept
10.6.1 Biocept Basic Information
10.6.2 Biocept Precision Cancer Diagnostic Tests Product Overview
10.6.3 Biocept Precision Cancer Diagnostic Tests Product Market Performance
10.6.4 Biocept Business Overview
10.6.5 Biocept Recent Developments
10.7 bioMerieux SA
10.7.1 bioMerieux SA Basic Information
10.7.2 bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
10.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Product Market Performance
10.7.4 bioMerieux SA Business Overview
10.7.5 bioMerieux SA Recent Developments
10.8 Canon Medical Systems Corporation
10.8.1 Canon Medical Systems Corporation Basic Information
10.8.2 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
10.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Market Performance
10.8.4 Canon Medical Systems Corporation Business Overview
10.8.5 Canon Medical Systems Corporation Recent Developments
10.9 Cynvenio Biosystems
10.9.1 Cynvenio Biosystems Basic Information
10.9.2 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
10.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Market Performance
10.9.4 Cynvenio Biosystems Business Overview
10.9.5 Cynvenio Biosystems Recent Developments
10.10 Danaher Corporation
10.10.1 Danaher Corporation Basic Information
10.10.2 Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
10.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Product Market Performance
10.10.4 Danaher Corporation Business Overview
10.10.5 Danaher Corporation Recent Developments
10.11 Epigenomics AG
10.11.1 Epigenomics AG Basic Information
10.11.2 Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
10.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Product Market Performance
10.11.4 Epigenomics AG Business Overview
10.11.5 Epigenomics AG Recent Developments
10.12 Exosome Diagnostics
10.12.1 Exosome Diagnostics Basic Information
10.12.2 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
10.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
10.12.4 Exosome Diagnostics Business Overview
10.12.5 Exosome Diagnostics Recent Developments
10.13 Foundation Medicine
10.13.1 Foundation Medicine Basic Information
10.13.2 Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
10.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Product Market Performance
10.13.4 Foundation Medicine Business Overview
10.13.5 Foundation Medicine Recent Developments
10.14 General Electric Company
10.14.1 General Electric Company Basic Information
10.14.2 General Electric Company Precision Cancer Diagnostic Tests Product Overview
10.14.3 General Electric Company Precision Cancer Diagnostic Tests Product Market Performance
10.14.4 General Electric Company Business Overview
10.14.5 General Electric Company Recent Developments
10.15 Genomic Health
10.15.1 Genomic Health Basic Information
10.15.2 Genomic Health Precision Cancer Diagnostic Tests Product Overview
10.15.3 Genomic Health Precision Cancer Diagnostic Tests Product Market Performance
10.15.4 Genomic Health Business Overview
10.15.5 Genomic Health Recent Developments
10.16 Hologic
10.16.1 Hologic Basic Information
10.16.2 Hologic Precision Cancer Diagnostic Tests Product Overview
10.16.3 Hologic Precision Cancer Diagnostic Tests Product Market Performance
10.16.4 Hologic Business Overview
10.16.5 Hologic Recent Developments
10.17 Illumina
10.17.1 Illumina Basic Information
10.17.2 Illumina Precision Cancer Diagnostic Tests Product Overview
10.17.3 Illumina Precision Cancer Diagnostic Tests Product Market Performance
10.17.4 Illumina Business Overview
10.17.5 Illumina Recent Developments
10.18 Menarini Silicon Biosystems SpA
10.18.1 Menarini Silicon Biosystems SpA Basic Information
10.18.2 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
10.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Market Performance
10.18.4 Menarini Silicon Biosystems SpA Business Overview
10.18.5 Menarini Silicon Biosystems SpA Recent Developments
10.19 Myriad Genetics
10.19.1 Myriad Genetics Basic Information
10.19.2 Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
10.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Product Market Performance
10.19.4 Myriad Genetics Business Overview
10.19.5 Myriad Genetics Recent Developments
10.20 NanoString Technologies
10.20.1 NanoString Technologies Basic Information
10.20.2 NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
10.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Product Market Performance
10.20.4 NanoString Technologies Business Overview
10.20.5 NanoString Technologies Recent Developments
10.21 Ortho Clinical Diagnostics
10.21.1 Ortho Clinical Diagnostics Basic Information
10.21.2 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
10.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
10.21.4 Ortho Clinical Diagnostics Business Overview
10.21.5 Ortho Clinical Diagnostics Recent Developments
10.22 QIAGEN N.V.
10.22.1 QIAGEN N.V. Basic Information
10.22.2 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
10.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Market Performance
10.22.4 QIAGEN N.V. Business Overview
10.22.5 QIAGEN N.V. Recent Developments
10.23 Randox Laboratories Ltd.
10.23.1 Randox Laboratories Ltd. Basic Information
10.23.2 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
10.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Market Performance
10.23.4 Randox Laboratories Ltd. Business Overview
10.23.5 Randox Laboratories Ltd. Recent Developments
10.24 Roche Holding AG
10.24.1 Roche Holding AG Basic Information
10.24.2 Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
10.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Product Market Performance
10.24.4 Roche Holding AG Business Overview
10.24.5 Roche Holding AG Recent Developments
10.25 Royal Philips N.V.
10.25.1 Royal Philips N.V. Basic Information
10.25.2 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
10.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Market Performance
10.25.4 Royal Philips N.V. Business Overview
10.25.5 Royal Philips N.V. Recent Developments
10.26 Siemens AG
10.26.1 Siemens AG Basic Information
10.26.2 Siemens AG Precision Cancer Diagnostic Tests Product Overview
10.26.3 Siemens AG Precision Cancer Diagnostic Tests Product Market Performance
10.26.4 Siemens AG Business Overview
10.26.5 Siemens AG Recent Developments
10.27 Thermo Fisher Scientific
10.27.1 Thermo Fisher Scientific Basic Information
10.27.2 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
10.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Market Performance
10.27.4 Thermo Fisher Scientific Business Overview
10.27.5 Thermo Fisher Scientific Recent Developments
10.28 Vela Diagnostics
10.28.1 Vela Diagnostics Basic Information
10.28.2 Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
10.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
10.28.4 Vela Diagnostics Business Overview
10.28.5 Vela Diagnostics Recent Developments
11 PRECISION CANCER DIAGNOSTIC TESTS MARKET FORECAST BY REGION
11.1 Global Precision Cancer Diagnostic Tests Market Size Forecast
11.2 Global Precision Cancer Diagnostic Tests Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country
11.2.3 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region
11.2.4 South America Precision Cancer Diagnostic Tests Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Precision Cancer Diagnostic Tests by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Precision Cancer Diagnostic Tests Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Precision Cancer Diagnostic Tests by Type (2026-2035)
12.1.2 Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Precision Cancer Diagnostic Tests by Type (2026-2035)
12.2 Global Precision Cancer Diagnostic Tests Market Forecast by Application (2026-2035)
12.2.1 Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application
12.2.2 Global Precision Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Precision Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Precision Cancer Diagnostic Tests Segment by Type
1.2.2 Precision Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRECISION CANCER DIAGNOSTIC TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Precision Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Precision Cancer Diagnostic Tests Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRECISION CANCER DIAGNOSTIC TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Precision Cancer Diagnostic Tests Product Life Cycle
3.3 Global Precision Cancer Diagnostic Tests Sales by Manufacturers (2020-2025)
3.4 Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2020-2025)
3.5 Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Precision Cancer Diagnostic Tests Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Precision Cancer Diagnostic Tests Market Competitive Situation and Trends
3.8.1 Precision Cancer Diagnostic Tests Market Concentration Rate
3.8.2 Global 5 and 10 Largest Precision Cancer Diagnostic Tests Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRECISION CANCER DIAGNOSTIC TESTS INDUSTRY CHAIN ANALYSIS
4.1 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRECISION CANCER DIAGNOSTIC TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Precision Cancer Diagnostic Tests Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Precision Cancer Diagnostic Tests Market
5.7 ESG Ratings of Leading Companies
6 PRECISION CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
6.3 Global Precision Cancer Diagnostic Tests Market Size by Type (2020-2025)
6.4 Global Precision Cancer Diagnostic Tests Price by Type (2020-2025)
7 PRECISION CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Precision Cancer Diagnostic Tests Market Sales by Application (2020-2025)
7.3 Global Precision Cancer Diagnostic Tests Market Size (M USD) by Application (2020-2025)
7.4 Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
8 PRECISION CANCER DIAGNOSTIC TESTS MARKET SALES BY REGION
8.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Region
8.2 Global Precision Cancer Diagnostic Tests Market Size by Region
8.2.1 Global Precision Cancer Diagnostic Tests Market Size by Region
8.2.2 Global Precision Cancer Diagnostic Tests Market Size by Region
8.3 North America
8.3.1 North America Precision Cancer Diagnostic Tests Sales by Country
8.3.2 North America Precision Cancer Diagnostic Tests Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Precision Cancer Diagnostic Tests Sales by Country
8.4.2 Europe Precision Cancer Diagnostic Tests Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Precision Cancer Diagnostic Tests Sales by Region
8.5.2 Asia Pacific Precision Cancer Diagnostic Tests Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Precision Cancer Diagnostic Tests Sales by Country
8.6.2 South America Precision Cancer Diagnostic Tests Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region
8.7.2 Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PRECISION CANCER DIAGNOSTIC TESTS MARKET PRODUCTION BY REGION
9.1 Global Production of Precision Cancer Diagnostic Tests by Region(2020-2025)
9.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
9.3 Global Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Precision Cancer Diagnostic Tests Production
9.4.1 North America Precision Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.4.2 North America Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Precision Cancer Diagnostic Tests Production
9.5.1 Europe Precision Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.5.2 Europe Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Precision Cancer Diagnostic Tests Production (2020-2025)
9.6.1 Japan Precision Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.6.2 Japan Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Precision Cancer Diagnostic Tests Production (2020-2025)
9.7.1 China Precision Cancer Diagnostic Tests Production Growth Rate (2020-2025)
9.7.2 China Precision Cancer Diagnostic Tests Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
10.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Agilent Technologies
10.2.1 Agilent Technologies Basic Information
10.2.2 Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
10.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Product Market Performance
10.2.4 Agilent Technologies Business Overview
10.2.5 Agilent Technologies SWOT Analysis
10.2.6 Agilent Technologies Recent Developments
10.3 Becton Dickinson and Company
10.3.1 Becton Dickinson and Company Basic Information
10.3.2 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
10.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Market Performance
10.3.4 Becton Dickinson and Company Business Overview
10.3.5 Becton Dickinson and Company SWOT Analysis
10.3.6 Becton Dickinson and Company Recent Developments
10.4 Bio-Rad Laboratories
10.4.1 Bio-Rad Laboratories Basic Information
10.4.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
10.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Market Performance
10.4.4 Bio-Rad Laboratories Business Overview
10.4.5 Bio-Rad Laboratories Recent Developments
10.5 Biocartis N.V.
10.5.1 Biocartis N.V. Basic Information
10.5.2 Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
10.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Product Market Performance
10.5.4 Biocartis N.V. Business Overview
10.5.5 Biocartis N.V. Recent Developments
10.6 Biocept
10.6.1 Biocept Basic Information
10.6.2 Biocept Precision Cancer Diagnostic Tests Product Overview
10.6.3 Biocept Precision Cancer Diagnostic Tests Product Market Performance
10.6.4 Biocept Business Overview
10.6.5 Biocept Recent Developments
10.7 bioMerieux SA
10.7.1 bioMerieux SA Basic Information
10.7.2 bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
10.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Product Market Performance
10.7.4 bioMerieux SA Business Overview
10.7.5 bioMerieux SA Recent Developments
10.8 Canon Medical Systems Corporation
10.8.1 Canon Medical Systems Corporation Basic Information
10.8.2 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
10.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Market Performance
10.8.4 Canon Medical Systems Corporation Business Overview
10.8.5 Canon Medical Systems Corporation Recent Developments
10.9 Cynvenio Biosystems
10.9.1 Cynvenio Biosystems Basic Information
10.9.2 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
10.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Market Performance
10.9.4 Cynvenio Biosystems Business Overview
10.9.5 Cynvenio Biosystems Recent Developments
10.10 Danaher Corporation
10.10.1 Danaher Corporation Basic Information
10.10.2 Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
10.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Product Market Performance
10.10.4 Danaher Corporation Business Overview
10.10.5 Danaher Corporation Recent Developments
10.11 Epigenomics AG
10.11.1 Epigenomics AG Basic Information
10.11.2 Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
10.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Product Market Performance
10.11.4 Epigenomics AG Business Overview
10.11.5 Epigenomics AG Recent Developments
10.12 Exosome Diagnostics
10.12.1 Exosome Diagnostics Basic Information
10.12.2 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
10.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
10.12.4 Exosome Diagnostics Business Overview
10.12.5 Exosome Diagnostics Recent Developments
10.13 Foundation Medicine
10.13.1 Foundation Medicine Basic Information
10.13.2 Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
10.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Product Market Performance
10.13.4 Foundation Medicine Business Overview
10.13.5 Foundation Medicine Recent Developments
10.14 General Electric Company
10.14.1 General Electric Company Basic Information
10.14.2 General Electric Company Precision Cancer Diagnostic Tests Product Overview
10.14.3 General Electric Company Precision Cancer Diagnostic Tests Product Market Performance
10.14.4 General Electric Company Business Overview
10.14.5 General Electric Company Recent Developments
10.15 Genomic Health
10.15.1 Genomic Health Basic Information
10.15.2 Genomic Health Precision Cancer Diagnostic Tests Product Overview
10.15.3 Genomic Health Precision Cancer Diagnostic Tests Product Market Performance
10.15.4 Genomic Health Business Overview
10.15.5 Genomic Health Recent Developments
10.16 Hologic
10.16.1 Hologic Basic Information
10.16.2 Hologic Precision Cancer Diagnostic Tests Product Overview
10.16.3 Hologic Precision Cancer Diagnostic Tests Product Market Performance
10.16.4 Hologic Business Overview
10.16.5 Hologic Recent Developments
10.17 Illumina
10.17.1 Illumina Basic Information
10.17.2 Illumina Precision Cancer Diagnostic Tests Product Overview
10.17.3 Illumina Precision Cancer Diagnostic Tests Product Market Performance
10.17.4 Illumina Business Overview
10.17.5 Illumina Recent Developments
10.18 Menarini Silicon Biosystems SpA
10.18.1 Menarini Silicon Biosystems SpA Basic Information
10.18.2 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
10.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Market Performance
10.18.4 Menarini Silicon Biosystems SpA Business Overview
10.18.5 Menarini Silicon Biosystems SpA Recent Developments
10.19 Myriad Genetics
10.19.1 Myriad Genetics Basic Information
10.19.2 Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
10.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Product Market Performance
10.19.4 Myriad Genetics Business Overview
10.19.5 Myriad Genetics Recent Developments
10.20 NanoString Technologies
10.20.1 NanoString Technologies Basic Information
10.20.2 NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
10.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Product Market Performance
10.20.4 NanoString Technologies Business Overview
10.20.5 NanoString Technologies Recent Developments
10.21 Ortho Clinical Diagnostics
10.21.1 Ortho Clinical Diagnostics Basic Information
10.21.2 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
10.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
10.21.4 Ortho Clinical Diagnostics Business Overview
10.21.5 Ortho Clinical Diagnostics Recent Developments
10.22 QIAGEN N.V.
10.22.1 QIAGEN N.V. Basic Information
10.22.2 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
10.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Market Performance
10.22.4 QIAGEN N.V. Business Overview
10.22.5 QIAGEN N.V. Recent Developments
10.23 Randox Laboratories Ltd.
10.23.1 Randox Laboratories Ltd. Basic Information
10.23.2 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
10.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Market Performance
10.23.4 Randox Laboratories Ltd. Business Overview
10.23.5 Randox Laboratories Ltd. Recent Developments
10.24 Roche Holding AG
10.24.1 Roche Holding AG Basic Information
10.24.2 Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
10.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Product Market Performance
10.24.4 Roche Holding AG Business Overview
10.24.5 Roche Holding AG Recent Developments
10.25 Royal Philips N.V.
10.25.1 Royal Philips N.V. Basic Information
10.25.2 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
10.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Market Performance
10.25.4 Royal Philips N.V. Business Overview
10.25.5 Royal Philips N.V. Recent Developments
10.26 Siemens AG
10.26.1 Siemens AG Basic Information
10.26.2 Siemens AG Precision Cancer Diagnostic Tests Product Overview
10.26.3 Siemens AG Precision Cancer Diagnostic Tests Product Market Performance
10.26.4 Siemens AG Business Overview
10.26.5 Siemens AG Recent Developments
10.27 Thermo Fisher Scientific
10.27.1 Thermo Fisher Scientific Basic Information
10.27.2 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
10.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Market Performance
10.27.4 Thermo Fisher Scientific Business Overview
10.27.5 Thermo Fisher Scientific Recent Developments
10.28 Vela Diagnostics
10.28.1 Vela Diagnostics Basic Information
10.28.2 Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
10.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
10.28.4 Vela Diagnostics Business Overview
10.28.5 Vela Diagnostics Recent Developments
11 PRECISION CANCER DIAGNOSTIC TESTS MARKET FORECAST BY REGION
11.1 Global Precision Cancer Diagnostic Tests Market Size Forecast
11.2 Global Precision Cancer Diagnostic Tests Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country
11.2.3 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region
11.2.4 South America Precision Cancer Diagnostic Tests Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Precision Cancer Diagnostic Tests by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Precision Cancer Diagnostic Tests Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Precision Cancer Diagnostic Tests by Type (2026-2035)
12.1.2 Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Precision Cancer Diagnostic Tests by Type (2026-2035)
12.2 Global Precision Cancer Diagnostic Tests Market Forecast by Application (2026-2035)
12.2.1 Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application
12.2.2 Global Precision Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Precision Cancer Diagnostic Tests Market Size by Type (M USD)
Table 4. Global Precision Cancer Diagnostic Tests Market Size by Application
Table 5. Precision Cancer Diagnostic Tests Market Size Comparison by Region (M USD)
Table 6. Global Precision Cancer Diagnostic Tests Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Precision Cancer Diagnostic Tests Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Precision Cancer Diagnostic Tests Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Precision Cancer Diagnostic Tests Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2025)
Table 11. Global Market Precision Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Precision Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Precision Cancer Diagnostic Tests Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Precision Cancer Diagnostic Tests Sales by Type (K Units)
Table 27. Global Precision Cancer Diagnostic Tests Market Size by Type (M USD)
Table 28. Global Precision Cancer Diagnostic Tests Sales (K Units) by Type (2020-2025)
Table 29. Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
Table 30. Global Precision Cancer Diagnostic Tests Market Size (M USD) by Type (2020-2025)
Table 31. Global Precision Cancer Diagnostic Tests Market Share by Type (2020-2025)
Table 32. Global Precision Cancer Diagnostic Tests Price (USD/Unit) by Type (2020-2025)
Table 33. Global Precision Cancer Diagnostic Tests Sales (K Units) by Application
Table 34. Global Precision Cancer Diagnostic Tests Market Size by Application
Table 35. Global Precision Cancer Diagnostic Tests Sales by Application (2020-2025) & (K Units)
Table 36. Global Precision Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
Table 37. Global Precision Cancer Diagnostic Tests Market Size by Application (2020-2025) & (M USD)
Table 38. Global Precision Cancer Diagnostic Tests Market Share by Application (2020-2025)
Table 39. Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
Table 40. Global Precision Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 41. Global Precision Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
Table 42. Global Precision Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 43. Global Precision Cancer Diagnostic Tests Market Size by Region (2020-2025)
Table 44. North America Precision Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 45. North America Precision Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Precision Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 47. Europe Precision Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Precision Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 50. South America Precision Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 51. South America Precision Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 54. Global Precision Cancer Diagnostic Tests Production (K Units) by Region(2020-2025)
Table 55. Global Precision Cancer Diagnostic Tests Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Precision Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
Table 57. Global Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
Table 64. Abbott Laboratories Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. Agilent Technologies Basic Information
Table 69. Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
Table 70. Agilent Technologies Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Agilent Technologies Business Overview
Table 72. Agilent Technologies SWOT Analysis
Table 73. Agilent Technologies Recent Developments
Table 74. Becton Dickinson and Company Basic Information
Table 75. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
Table 76. Becton Dickinson and Company Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Becton Dickinson and Company Business Overview
Table 78. Becton Dickinson and Company SWOT Analysis
Table 79. Becton Dickinson and Company Recent Developments
Table 80. Bio-Rad Laboratories Basic Information
Table 81. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
Table 82. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bio-Rad Laboratories Business Overview
Table 84. Bio-Rad Laboratories Recent Developments
Table 85. Biocartis N.V. Basic Information
Table 86. Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
Table 87. Biocartis N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Biocartis N.V. Business Overview
Table 89. Biocartis N.V. Recent Developments
Table 90. Biocept Basic Information
Table 91. Biocept Precision Cancer Diagnostic Tests Product Overview
Table 92. Biocept Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biocept Business Overview
Table 94. Biocept Recent Developments
Table 95. bioMerieux SA Basic Information
Table 96. bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
Table 97. bioMerieux SA Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. bioMerieux SA Business Overview
Table 99. bioMerieux SA Recent Developments
Table 100. Canon Medical Systems Corporation Basic Information
Table 101. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
Table 102. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Canon Medical Systems Corporation Business Overview
Table 104. Canon Medical Systems Corporation Recent Developments
Table 105. Cynvenio Biosystems Basic Information
Table 106. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
Table 107. Cynvenio Biosystems Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cynvenio Biosystems Business Overview
Table 109. Cynvenio Biosystems Recent Developments
Table 110. Danaher Corporation Basic Information
Table 111. Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
Table 112. Danaher Corporation Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Danaher Corporation Business Overview
Table 114. Danaher Corporation Recent Developments
Table 115. Epigenomics AG Basic Information
Table 116. Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
Table 117. Epigenomics AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Epigenomics AG Business Overview
Table 119. Epigenomics AG Recent Developments
Table 120. Exosome Diagnostics Basic Information
Table 121. Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 122. Exosome Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Exosome Diagnostics Business Overview
Table 124. Exosome Diagnostics Recent Developments
Table 125. Foundation Medicine Basic Information
Table 126. Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
Table 127. Foundation Medicine Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Foundation Medicine Business Overview
Table 129. Foundation Medicine Recent Developments
Table 130. General Electric Company Basic Information
Table 131. General Electric Company Precision Cancer Diagnostic Tests Product Overview
Table 132. General Electric Company Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. General Electric Company Business Overview
Table 134. General Electric Company Recent Developments
Table 135. Genomic Health Basic Information
Table 136. Genomic Health Precision Cancer Diagnostic Tests Product Overview
Table 137. Genomic Health Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Genomic Health Business Overview
Table 139. Genomic Health Recent Developments
Table 140. Hologic Basic Information
Table 141. Hologic Precision Cancer Diagnostic Tests Product Overview
Table 142. Hologic Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Hologic Business Overview
Table 144. Hologic Recent Developments
Table 145. Illumina Basic Information
Table 146. Illumina Precision Cancer Diagnostic Tests Product Overview
Table 147. Illumina Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Illumina Business Overview
Table 149. Illumina Recent Developments
Table 150. Menarini Silicon Biosystems SpA Basic Information
Table 151. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
Table 152. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Menarini Silicon Biosystems SpA Business Overview
Table 154. Menarini Silicon Biosystems SpA Recent Developments
Table 155. Myriad Genetics Basic Information
Table 156. Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
Table 157. Myriad Genetics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Myriad Genetics Business Overview
Table 159. Myriad Genetics Recent Developments
Table 160. NanoString Technologies Basic Information
Table 161. NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
Table 162. NanoString Technologies Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. NanoString Technologies Business Overview
Table 164. NanoString Technologies Recent Developments
Table 165. Ortho Clinical Diagnostics Basic Information
Table 166. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 167. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Ortho Clinical Diagnostics Business Overview
Table 169. Ortho Clinical Diagnostics Recent Developments
Table 170. QIAGEN N.V. Basic Information
Table 171. QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
Table 172. QIAGEN N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. QIAGEN N.V. Business Overview
Table 174. QIAGEN N.V. Recent Developments
Table 175. Randox Laboratories Ltd. Basic Information
Table 176. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
Table 177. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Randox Laboratories Ltd. Business Overview
Table 179. Randox Laboratories Ltd. Recent Developments
Table 180. Roche Holding AG Basic Information
Table 181. Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
Table 182. Roche Holding AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Roche Holding AG Business Overview
Table 184. Roche Holding AG Recent Developments
Table 185. Royal Philips N.V. Basic Information
Table 186. Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
Table 187. Royal Philips N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Royal Philips N.V. Business Overview
Table 189. Royal Philips N.V. Recent Developments
Table 190. Siemens AG Basic Information
Table 191. Siemens AG Precision Cancer Diagnostic Tests Product Overview
Table 192. Siemens AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Siemens AG Business Overview
Table 194. Siemens AG Recent Developments
Table 195. Thermo Fisher Scientific Basic Information
Table 196. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
Table 197. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. Thermo Fisher Scientific Business Overview
Table 199. Thermo Fisher Scientific Recent Developments
Table 200. Vela Diagnostics Basic Information
Table 201. Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 202. Vela Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 203. Vela Diagnostics Business Overview
Table 204. Vela Diagnostics Recent Developments
Table 205. Global Precision Cancer Diagnostic Tests Sales Forecast by Region (2026-2035) & (K Units)
Table 206. Global Precision Cancer Diagnostic Tests Market Size Forecast by Region (2026-2035) & (M USD)
Table 207. North America Precision Cancer Diagnostic Tests Sales Forecast by Country (2026-2035) & (K Units)
Table 208. North America Precision Cancer Diagnostic Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 209. Europe Precision Cancer Diagnostic Tests Sales Forecast by Country (2026-2035) & (K Units)
Table 210. Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 211. Asia Pacific Precision Cancer Diagnostic Tests Sales Forecast by Region (2026-2035) & (K Units)
Table 212. Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region (2026-2035) & (M USD)
Table 213. South America Precision Cancer Diagnostic Tests Sales Forecast by Country (2026-2035) & (K Units)
Table 214. South America Precision Cancer Diagnostic Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 215. Middle East and Africa Precision Cancer Diagnostic Tests Sales Forecast by Country (2026-2035) & (Units)
Table 216. Middle East and Africa Precision Cancer Diagnostic Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 217. Global Precision Cancer Diagnostic Tests Sales Forecast by Type (2026-2035) & (K Units)
Table 218. Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2026-2035) & (M USD)
Table 219. Global Precision Cancer Diagnostic Tests Price Forecast by Type (2026-2035) & (USD/Unit)
Table 220. Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2026-2035)
Table 221. Global Precision Cancer Diagnostic Tests Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Precision Cancer Diagnostic Tests Market Size by Type (M USD)
Table 4. Global Precision Cancer Diagnostic Tests Market Size by Application
Table 5. Precision Cancer Diagnostic Tests Market Size Comparison by Region (M USD)
Table 6. Global Precision Cancer Diagnostic Tests Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Precision Cancer Diagnostic Tests Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Precision Cancer Diagnostic Tests Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Precision Cancer Diagnostic Tests Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2025)
Table 11. Global Market Precision Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Precision Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Precision Cancer Diagnostic Tests Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Precision Cancer Diagnostic Tests Sales by Type (K Units)
Table 27. Global Precision Cancer Diagnostic Tests Market Size by Type (M USD)
Table 28. Global Precision Cancer Diagnostic Tests Sales (K Units) by Type (2020-2025)
Table 29. Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
Table 30. Global Precision Cancer Diagnostic Tests Market Size (M USD) by Type (2020-2025)
Table 31. Global Precision Cancer Diagnostic Tests Market Share by Type (2020-2025)
Table 32. Global Precision Cancer Diagnostic Tests Price (USD/Unit) by Type (2020-2025)
Table 33. Global Precision Cancer Diagnostic Tests Sales (K Units) by Application
Table 34. Global Precision Cancer Diagnostic Tests Market Size by Application
Table 35. Global Precision Cancer Diagnostic Tests Sales by Application (2020-2025) & (K Units)
Table 36. Global Precision Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
Table 37. Global Precision Cancer Diagnostic Tests Market Size by Application (2020-2025) & (M USD)
Table 38. Global Precision Cancer Diagnostic Tests Market Share by Application (2020-2025)
Table 39. Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
Table 40. Global Precision Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 41. Global Precision Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
Table 42. Global Precision Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 43. Global Precision Cancer Diagnostic Tests Market Size by Region (2020-2025)
Table 44. North America Precision Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 45. North America Precision Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Precision Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 47. Europe Precision Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Precision Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 50. South America Precision Cancer Diagnostic Tests Sales by Country (2020-2025) & (K Units)
Table 51. South America Precision Cancer Diagnostic Tests Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Region (2020-2025) & (M USD)
Table 54. Global Precision Cancer Diagnostic Tests Production (K Units) by Region(2020-2025)
Table 55. Global Precision Cancer Diagnostic Tests Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Precision Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
Table 57. Global Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Precision Cancer Diagnostic Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
Table 64. Abbott Laboratories Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. Agilent Technologies Basic Information
Table 69. Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
Table 70. Agilent Technologies Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Agilent Technologies Business Overview
Table 72. Agilent Technologies SWOT Analysis
Table 73. Agilent Technologies Recent Developments
Table 74. Becton Dickinson and Company Basic Information
Table 75. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
Table 76. Becton Dickinson and Company Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Becton Dickinson and Company Business Overview
Table 78. Becton Dickinson and Company SWOT Analysis
Table 79. Becton Dickinson and Company Recent Developments
Table 80. Bio-Rad Laboratories Basic Information
Table 81. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
Table 82. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bio-Rad Laboratories Business Overview
Table 84. Bio-Rad Laboratories Recent Developments
Table 85. Biocartis N.V. Basic Information
Table 86. Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
Table 87. Biocartis N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Biocartis N.V. Business Overview
Table 89. Biocartis N.V. Recent Developments
Table 90. Biocept Basic Information
Table 91. Biocept Precision Cancer Diagnostic Tests Product Overview
Table 92. Biocept Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biocept Business Overview
Table 94. Biocept Recent Developments
Table 95. bioMerieux SA Basic Information
Table 96. bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
Table 97. bioMerieux SA Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. bioMerieux SA Business Overview
Table 99. bioMerieux SA Recent Developments
Table 100. Canon Medical Systems Corporation Basic Information
Table 101. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
Table 102. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Canon Medical Systems Corporation Business Overview
Table 104. Canon Medical Systems Corporation Recent Developments
Table 105. Cynvenio Biosystems Basic Information
Table 106. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
Table 107. Cynvenio Biosystems Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cynvenio Biosystems Business Overview
Table 109. Cynvenio Biosystems Recent Developments
Table 110. Danaher Corporation Basic Information
Table 111. Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
Table 112. Danaher Corporation Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Danaher Corporation Business Overview
Table 114. Danaher Corporation Recent Developments
Table 115. Epigenomics AG Basic Information
Table 116. Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
Table 117. Epigenomics AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Epigenomics AG Business Overview
Table 119. Epigenomics AG Recent Developments
Table 120. Exosome Diagnostics Basic Information
Table 121. Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 122. Exosome Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Exosome Diagnostics Business Overview
Table 124. Exosome Diagnostics Recent Developments
Table 125. Foundation Medicine Basic Information
Table 126. Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
Table 127. Foundation Medicine Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Foundation Medicine Business Overview
Table 129. Foundation Medicine Recent Developments
Table 130. General Electric Company Basic Information
Table 131. General Electric Company Precision Cancer Diagnostic Tests Product Overview
Table 132. General Electric Company Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. General Electric Company Business Overview
Table 134. General Electric Company Recent Developments
Table 135. Genomic Health Basic Information
Table 136. Genomic Health Precision Cancer Diagnostic Tests Product Overview
Table 137. Genomic Health Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Genomic Health Business Overview
Table 139. Genomic Health Recent Developments
Table 140. Hologic Basic Information
Table 141. Hologic Precision Cancer Diagnostic Tests Product Overview
Table 142. Hologic Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Hologic Business Overview
Table 144. Hologic Recent Developments
Table 145. Illumina Basic Information
Table 146. Illumina Precision Cancer Diagnostic Tests Product Overview
Table 147. Illumina Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Illumina Business Overview
Table 149. Illumina Recent Developments
Table 150. Menarini Silicon Biosystems SpA Basic Information
Table 151. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
Table 152. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Menarini Silicon Biosystems SpA Business Overview
Table 154. Menarini Silicon Biosystems SpA Recent Developments
Table 155. Myriad Genetics Basic Information
Table 156. Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
Table 157. Myriad Genetics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Myriad Genetics Business Overview
Table 159. Myriad Genetics Recent Developments
Table 160. NanoString Technologies Basic Information
Table 161. NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
Table 162. NanoString Technologies Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. NanoString Technologies Business Overview
Table 164. NanoString Technologies Recent Developments
Table 165. Ortho Clinical Diagnostics Basic Information
Table 166. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 167. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Ortho Clinical Diagnostics Business Overview
Table 169. Ortho Clinical Diagnostics Recent Developments
Table 170. QIAGEN N.V. Basic Information
Table 171. QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
Table 172. QIAGEN N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. QIAGEN N.V. Business Overview
Table 174. QIAGEN N.V. Recent Developments
Table 175. Randox Laboratories Ltd. Basic Information
Table 176. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
Table 177. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Randox Laboratories Ltd. Business Overview
Table 179. Randox Laboratories Ltd. Recent Developments
Table 180. Roche Holding AG Basic Information
Table 181. Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
Table 182. Roche Holding AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Roche Holding AG Business Overview
Table 184. Roche Holding AG Recent Developments
Table 185. Royal Philips N.V. Basic Information
Table 186. Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
Table 187. Royal Philips N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Royal Philips N.V. Business Overview
Table 189. Royal Philips N.V. Recent Developments
Table 190. Siemens AG Basic Information
Table 191. Siemens AG Precision Cancer Diagnostic Tests Product Overview
Table 192. Siemens AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Siemens AG Business Overview
Table 194. Siemens AG Recent Developments
Table 195. Thermo Fisher Scientific Basic Information
Table 196. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
Table 197. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. Thermo Fisher Scientific Business Overview
Table 199. Thermo Fisher Scientific Recent Developments
Table 200. Vela Diagnostics Basic Information
Table 201. Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 202. Vela Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 203. Vela Diagnostics Business Overview
Table 204. Vela Diagnostics Recent Developments
Table 205. Global Precision Cancer Diagnostic Tests Sales Forecast by Region (2026-2035) & (K Units)
Table 206. Global Precision Cancer Diagnostic Tests Market Size Forecast by Region (2026-2035) & (M USD)
Table 207. North America Precision Cancer Diagnostic Tests Sales Forecast by Country (2026-2035) & (K Units)
Table 208. North America Precision Cancer Diagnostic Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 209. Europe Precision Cancer Diagnostic Tests Sales Forecast by Country (2026-2035) & (K Units)
Table 210. Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 211. Asia Pacific Precision Cancer Diagnostic Tests Sales Forecast by Region (2026-2035) & (K Units)
Table 212. Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region (2026-2035) & (M USD)
Table 213. South America Precision Cancer Diagnostic Tests Sales Forecast by Country (2026-2035) & (K Units)
Table 214. South America Precision Cancer Diagnostic Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 215. Middle East and Africa Precision Cancer Diagnostic Tests Sales Forecast by Country (2026-2035) & (Units)
Table 216. Middle East and Africa Precision Cancer Diagnostic Tests Market Size Forecast by Country (2026-2035) & (M USD)
Table 217. Global Precision Cancer Diagnostic Tests Sales Forecast by Type (2026-2035) & (K Units)
Table 218. Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2026-2035) & (M USD)
Table 219. Global Precision Cancer Diagnostic Tests Price Forecast by Type (2026-2035) & (USD/Unit)
Table 220. Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2026-2035)
Table 221. Global Precision Cancer Diagnostic Tests Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Precision Cancer Diagnostic Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Precision Cancer Diagnostic Tests Market Size (M USD), 2025-2035
Figure 5. Global Precision Cancer Diagnostic Tests Market Size (M USD) (2020-2035)
Figure 6. Global Precision Cancer Diagnostic Tests Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Precision Cancer Diagnostic Tests Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Precision Cancer Diagnostic Tests Product Life Cycle
Figure 13. Precision Cancer Diagnostic Tests Sales Share by Manufacturers in 2025
Figure 14. Global Precision Cancer Diagnostic Tests Revenue Share by Manufacturers in 2025
Figure 15. Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Precision Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Precision Cancer Diagnostic Tests Revenue in 2025
Figure 18. Industry Chain Map of Precision Cancer Diagnostic Tests
Figure 19. Global Precision Cancer Diagnostic Tests Market PEST Analysis
Figure 20. Global Precision Cancer Diagnostic Tests Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Precision Cancer Diagnostic Tests Market Share by Type
Figure 27. Sales Market Share of Precision Cancer Diagnostic Tests by Type (2020-2025)
Figure 28. Sales Market Share of Precision Cancer Diagnostic Tests by Type in 2025
Figure 29. Market Share of Precision Cancer Diagnostic Tests by Type (2020-2025)
Figure 30. Market Share of Precision Cancer Diagnostic Tests by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Precision Cancer Diagnostic Tests Market Share by Application
Figure 33. Global Precision Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
Figure 34. Global Precision Cancer Diagnostic Tests Sales Market Share by Application in 2025
Figure 35. Global Precision Cancer Diagnostic Tests Market Share by Application (2020-2025)
Figure 36. Global Precision Cancer Diagnostic Tests Market Share by Application in 2025
Figure 37. Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
Figure 38. Global Precision Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
Figure 39. Global Precision Cancer Diagnostic Tests Market Size by Region (2020-2025)
Figure 40. North America Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Precision Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 43. North America Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Precision Cancer Diagnostic Tests Market Size by Country in 2024
Figure 45. U.S. Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Precision Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Precision Cancer Diagnostic Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Precision Cancer Diagnostic Tests Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Precision Cancer Diagnostic Tests Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Precision Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 53. Europe Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Precision Cancer Diagnostic Tests Market Size by Country in 2024
Figure 55. Germany Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Precision Cancer Diagnostic Tests Sales Market Share by Region in 2024
Figure 67. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Region in 2024
Figure 68. China Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 79. South America Precision Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 80. South America Precision Cancer Diagnostic Tests Market Size and Growth Rate (M USD)
Figure 81. South America Precision Cancer Diagnostic Tests Market Size by Country in 2024
Figure 82. Brazil Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Precision Cancer Diagnostic Tests Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Precision Cancer Diagnostic Tests Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Region in 2024
Figure 92. Saudi Arabia Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Precision Cancer Diagnostic Tests Production Market Share by Region (2020-2025)
Figure 103. North America Precision Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Precision Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Precision Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 106. China Precision Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Precision Cancer Diagnostic Tests Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Precision Cancer Diagnostic Tests Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Precision Cancer Diagnostic Tests Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Precision Cancer Diagnostic Tests Market Share Forecast by Type (2026-2035)
Figure 111. Global Precision Cancer Diagnostic Tests Sales Forecast by Application (2026-2035)
Figure 112. Global Precision Cancer Diagnostic Tests Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Precision Cancer Diagnostic Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Precision Cancer Diagnostic Tests Market Size (M USD), 2025-2035
Figure 5. Global Precision Cancer Diagnostic Tests Market Size (M USD) (2020-2035)
Figure 6. Global Precision Cancer Diagnostic Tests Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Precision Cancer Diagnostic Tests Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Precision Cancer Diagnostic Tests Product Life Cycle
Figure 13. Precision Cancer Diagnostic Tests Sales Share by Manufacturers in 2025
Figure 14. Global Precision Cancer Diagnostic Tests Revenue Share by Manufacturers in 2025
Figure 15. Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Precision Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Precision Cancer Diagnostic Tests Revenue in 2025
Figure 18. Industry Chain Map of Precision Cancer Diagnostic Tests
Figure 19. Global Precision Cancer Diagnostic Tests Market PEST Analysis
Figure 20. Global Precision Cancer Diagnostic Tests Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Precision Cancer Diagnostic Tests Market Share by Type
Figure 27. Sales Market Share of Precision Cancer Diagnostic Tests by Type (2020-2025)
Figure 28. Sales Market Share of Precision Cancer Diagnostic Tests by Type in 2025
Figure 29. Market Share of Precision Cancer Diagnostic Tests by Type (2020-2025)
Figure 30. Market Share of Precision Cancer Diagnostic Tests by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Precision Cancer Diagnostic Tests Market Share by Application
Figure 33. Global Precision Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
Figure 34. Global Precision Cancer Diagnostic Tests Sales Market Share by Application in 2025
Figure 35. Global Precision Cancer Diagnostic Tests Market Share by Application (2020-2025)
Figure 36. Global Precision Cancer Diagnostic Tests Market Share by Application in 2025
Figure 37. Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2020-2025)
Figure 38. Global Precision Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
Figure 39. Global Precision Cancer Diagnostic Tests Market Size by Region (2020-2025)
Figure 40. North America Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Precision Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 43. North America Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Precision Cancer Diagnostic Tests Market Size by Country in 2024
Figure 45. U.S. Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Precision Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Precision Cancer Diagnostic Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Precision Cancer Diagnostic Tests Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Precision Cancer Diagnostic Tests Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Precision Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 53. Europe Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Precision Cancer Diagnostic Tests Market Size by Country in 2024
Figure 55. Germany Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Precision Cancer Diagnostic Tests Sales Market Share by Region in 2024
Figure 67. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Region in 2024
Figure 68. China Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 79. South America Precision Cancer Diagnostic Tests Sales Market Share by Country in 2024
Figure 80. South America Precision Cancer Diagnostic Tests Market Size and Growth Rate (M USD)
Figure 81. South America Precision Cancer Diagnostic Tests Market Size by Country in 2024
Figure 82. Brazil Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Precision Cancer Diagnostic Tests Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Precision Cancer Diagnostic Tests Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Region in 2024
Figure 92. Saudi Arabia Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Precision Cancer Diagnostic Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Precision Cancer Diagnostic Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Precision Cancer Diagnostic Tests Production Market Share by Region (2020-2025)
Figure 103. North America Precision Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Precision Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Precision Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 106. China Precision Cancer Diagnostic Tests Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Precision Cancer Diagnostic Tests Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Precision Cancer Diagnostic Tests Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Precision Cancer Diagnostic Tests Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Precision Cancer Diagnostic Tests Market Share Forecast by Type (2026-2035)
Figure 111. Global Precision Cancer Diagnostic Tests Sales Forecast by Application (2026-2035)
Figure 112. Global Precision Cancer Diagnostic Tests Market Share Forecast by Application (2026-2035)
